Flanders Vaccine

Flanders Vaccine aims to stimulate innovation in vaccine related research & business as well as to catalyse public-private partnerships. Flanders Vaccine brings together large companiers. SMEs with vaccine activities (active in vaccine development & delivery and biostatics), ROs, universities, university hospitals and research institutes.

Aims & Mission Statement

Flanders Vaccine is a non-profit, strategy-driven platform for academic, industrial and public stakeholders with relevant expertise in human and animal immunotherapeutics and vaccines. Flanders Vaccine brings together universities, public and private hospitals, research centres, SMEs, pharma, competence providers, patient organisations, and government bodies to develop novel immunological health solutions and the vaccines of the future.

 

Flanders Vaccine supports the development of immunotherapeutics and vaccines for both prophylactic and therapeutic targets in humans and animals by facilitating the exchange of know-how and complementary innovative technologies between academia and industry. The Flanders vaccine platform can be seen as an integrated tool that gives rise to more and better partnerships; that prepares us better for future calls for funding; that enables us to network at inspiring meetings and conferences; that generates visibility and attracts significant attention from national and international experts, stakeholders and organisations.

 

Why joining?

 

    • Member profile and link to your organisation on the member page
    • Member profile and organisation included in the “Search for partners” database
    • Publication of press releases, event announcements, job openings,… on our website
    • on upcoming events & conferences
    • on upcoming funding opportunities and calls for project proposals
    • on courses on vaccines & vaccine related research
    • on upcoming PhD defenses in the vaccine field
    • Reduced-fee entrance to member meetings (at least 4 times a year) and other events organized by Flanders vaccine.
    • Proactive assembly of selected R&D programmes of common interest
    • Representation of your company/organization by the Flanders vaccine delegation on (inter)national events & conferences

 

More info?

 

More info?

For any further information about this platform, please do not hesitate to get in touch with our Managing Director

Alternate Text

Henk Joos

Managing Director

| |